Patent details
300982
Product Name:
Certolizumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300982
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3059314
Status:
Withdrawn
Application number:
300982
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)
Marketing Authorization
Marketing Authorization Number:
EU/1/09/544/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
06/10/2009
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
24/04/2019
First Marketing Authorization date:
06/10/2009
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/04/2019
SPC/SPC Extension Expiration Date:
05/10/2024
Lapsed By Expiration Date:
Withdrawal date:
23/10/2019
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
24/04/2019
Name:
UCB Pharma, S.A.
Address:
Allée de la Recherche 60, 1070 BRUXELLES, Belgium (BE)
Agent
Name:
ir. H.A. Witmans c.s.
From:
24/04/2019
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
44/19
Publication date:
30/10/2019
Description:
Lapse or annulment
2
Bulletin Heading:
VRB
Journal edition number:
19/19
Publication date:
08/05/2019
Description:
Corrections on earlier publications
3
Bulletin Heading:
SPC
Journal edition number:
18/19
Publication date:
01/05/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
29/10/2019
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/7/8/2/0/0800402872/docs/300982_4_outgoingcorrespondence20191029123707693.pdf
24/10/2019
Incoming Correspondence Paper
Withdrawal of a request
1
PDF
/2/7/8/2/0/0800402872/docs/300982_3_incomingcorrespondencepaper20191025112138682.pdf
06/05/2019
Front Page
Front Page
1
PDF
/2/7/8/2/0/0800402872/docs/300982_0_i9frontpage20190506135043015.pdf
06/05/2019
Publication
Publication
1
PDF
/2/7/8/2/0/0800402872/docs/300982_10_i9document20190506135044125.pdf
03/05/2019
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/7/8/2/0/0800402872/docs/300982_8_271283l174.pdf
25/04/2019
SPC Documents
Summary of the characteristics of the product
16
PDF
/2/7/8/2/0/0800402872/docs/300982_1_supplprotectioncertificate20190426105158126.pdf
25/04/2019
SPC Documents
Marketing Authorization SPC
4
PDF
/2/7/8/2/0/0800402872/docs/300982_5_supplprotectioncertificate20190426105158060.pdf
25/04/2019
SPC Documents
Accompanying letter SPC
2
PDF
/2/7/8/2/0/0800402872/docs/300982_6_supplprotectioncertificate20190426105157992.pdf
25/04/2019
SPC Documents
Annex SPC
22
PDF
/2/7/8/2/0/0800402872/docs/300982_7_supplprotectioncertificate20190426105158315.pdf
25/04/2019
SPC Documents
Annex SPC
3
PDF
/2/7/8/2/0/0800402872/docs/300982_9_supplprotectioncertificate20190426105158239.pdf
25/04/2019
Application Form
First filed application form
3
PDF
/2/7/8/2/0/0800402872/docs/300982_11_applicationform20190426105157841.pdf
24/04/2019
SPC Documents
Mail SPC
53
PDF
/2/7/8/2/0/0800402872/docs/300982_2_supplprotectioncertificate20190426015244932.pdf